Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss

Pablo Ortiz-Lazareno, Alejandro Bravo-Cuellar, José Lerma-Díaz, Luis Jave-Suárez, Adriana Aguilar-Lemarroy, Jorge Domínguez-Rodríguez, Oscar González-Ramella, Ruth De Célis, Paulina Gómez-Lomelí, Georgina Hernández-Flores
  • Cancer Cell International, January 2014, Springer Science + Business Media
  • DOI: 10.1186/1475-2867-14-13
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Luis F Jave-Suarez